Markets | | Kroger’s (KR)management made two major missteps with the Restock Kroger plans. The first was their overaggressive plans to grow business in an attempt to compete with Walmart (WMT), Target (TGT), and Amazon (AMZN). The second was failing to realize the mistake soon enough. Now, with the compet... Read the Full Story |
|
From Our Partners | | Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge.
Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks.
Stream his free presentation to get every buy and sell recommendation with no membership or credit card required. | | Watch Marc Chaikin's free presentation and get his full buy-and-sell list today |
|
Markets | | Salesforce.com (CRM) reported earnings this morning and shares are tumbling. The company reported a strong 33% topline growth for the 3rd quarter and provided robust guidance yet not quite good enough for investors. What we have is a classic case of unfulfilled expectations in an overexuberant marke... Read the Full Story |
|
Markets | |
Have you ever heard a trader talking about “reading the tape”? This is a term that advanced traders use to describe looking at Level II quotes. Level II quotes are great for traders because they allow us to get a little more information about the magnitude of the buying and selling of ... Read the Full Story |
|
From Our Partners | | Hedge funds are rotating out of AI hype and into the hardware layer powering it. New research identifies three profitable U.S. infrastructure companies leading this shift.
One just posted 76% year-over-year data-center growth. Another holds a $12 billion backlog from global hyperscalers. A third is generating 59%+ gross margins on next-gen chips. | | Access the full analysis, price setups, and catalysts now |
|
Markets | | Shares of Veeva Systems (NYSE: VEEV) kept investors guessing after the company’s Q3 earnings last week. The stock whipped around a 12% range from Tuesday’s close on Wednesday following the release the previous evening. With markets shut on Thursday, they went into the Thanksgiving holida... Read the Full Story |
|
Healthcare | |
Pharmaceutical stocks are an important and interesting part of the healthcare market, and of the overall market as well. For investors who are interested in learning more about the pharmaceutical industry, a good place to start is with the following companies, which are some of the largest pharmac... Read the Full Story |
|
|
Markets | |
Money makes the world go around—at least in terms of driving a complex economy. Financial stocks are stocks issued by companies in the business of finance: banks, investment houses, credit unions, credit cards, and payment processing companies. These companies help individuals and organizati... Read the Full Story |
|
Markets | |
Admittedly, Under Armour (NYSE:UAA) does still have some panache in the market and some impressive connections to the world of fighting sports, the stock has been taking a beating worse than anything seen in the ring lately. However, it turns out that Under Armour does have at least one force in i... Read the Full Story |
|
Markets | |
Procter & Gamble stock (NYSE:PG) is up over 24% in 2019. One reason for investor optimism is that at several points this year, the stock has used a prior level of support to propel the stock to higher highs.
That same scenario seems to be playing out right now. After a post-earnings spike, PG... Read the Full Story |
|
Markets | |
The Conference Board released the Consumer Confidence numbers for November. The number came in at 125.5. The number did not meet analysts’ expectations for a 128.2 reading. The 125.5 number was the fourth straight month that the number declined and was the lower reading since the spring.
Th... Read the Full Story |
|
Markets | | Shares of Foot Locker (NYSE: FL) were down almost 3% on Friday after the company reported third-quarter earnings. EPS beat estimates but revenue fell below where analysts were expecting. The miss here along with narrowing revenue guidance from management fed the bears and sent shares down.
The stoc... Read the Full Story |
|
The Early Bird Stock Of The Day Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotics to treat metabolic diseases in the United States. Its pipeline include SYNB1618, an orally administered, non-systemically absorbed drug candidate to treat phenylketonuria; SYNB1934, an orally administered, non-systemically absorbed drug candidate, which is in Phase III clinical trial to treat phenylketonuria; SYNB1353, an orally administered, non-systemically absorbed drug candidate, which is in Phase I clinical to treat homocystinuria; SYNB8802, an orally administered, non-systemically absorbed drug candidate that is in Phase II clinical trial for the treatment of enteric hyperoxaluria; and SYNB2081 to lower uric acid for the potential treatment of gout. The company has a collaboration agreement with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc. for the research and pre-clinical development of a synthetic biotic medicine for the treatment of inflammatory bowel disease; and Ginkgo Bioworks, Inc. Synlogic, Inc. is based in Cambridge, Massachusetts. | | View Today's Stock Pick |
|
